Articles about Pharmaceuticals

Iridius, led by Microsoft and AWS vets, raises $8.6M to crack AI’s regulatory compliance bottleneck

Seattle startup Iridius, founded by former Microsoft and AWS leaders, is building software that embeds regulatory compliance into AI systems as they run. Accenture is both an investor and a strategic partner. Read More

Seattle Genetics stock jumps 17% on breast cancer drug trial success

Shares of cancer drug maker Seattle Genetics soared more than 17 percent Monday morning following positive results for a new… Read More

Seattle nonprofit Sage Bionetworks joins $37M national effort to hunt for Alzheimer’s drugs

Seattle-based nonprofit Sage Bionetworks is leading a heavily funded national effort to find new drugs to fight Alzheimer’s, a disease… Read More

Microsoft will use AI to supercharge Novartis’ giant drug-development engine

Microsoft has reached a deal with pharmaceutical giant Novartis that aims to bring the power of artificial intelligence to drug… Read More

Hearing-loss drugmaker Sound Pharmaceuticals posts strong clinical results, eyes a $100M IPO

Sound Pharmaceuticals, a Seattle-based drugmaker that is creating a first-of-its-kind treatment for hearing loss, recently reported encouraging top-line results from… Read More

Seattle Genetics shares slump after losses grow

Seattle Genetics on Thursday reported higher-than-expected losses for the fourth quarter, sending shares down 8 percent in after-hours trading. Quarterly… Read More